REFR:NASDAQResearch Frontiers Incorporated Analysis
Data as of 2026-04-28 - not real-time
$0.95
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical analysis shows the 20‑day SMA (≈0.95) sitting below both the 50‑day SMA (≈0.97) and the 200‑day SMA (≈1.39), confirming a bearish price structure. The RSI is near 49, indicating a lack of clear momentum, while the MACD histogram is modestly positive, suggesting a brief bullish impulse that is outweighed by the broader downtrend. Volume is trending upward, yet the stock trades in a very narrow range between $0.94 and $0.99, far below its 52‑week high of $2.70. Fundamentals are deeply distressed: revenue has collapsed by roughly 60%, margins are negative across the board, and the company reports a max drawdown of over 66% with a negative EBITDA exceeding $2 million. Valuation multiples are extreme, with a price‑to‑book near 34 and a price‑to‑sales above 29, while earnings are negative, yielding a forward P/E of –15.8. The firm carries a high debt‑to‑equity ratio (>120) and a negative cash flow profile, raising solvency concerns. Beta (≈1.08) and a 30‑day volatility of nearly 97% signal pronounced price swings, and the Fear‑Greed Index at 89.25 reflects an “Extreme Greed” market mood that may be unsustainable for such a fragile ticker. No dividend is paid, eliminating any income cushion. In sum, the convergence of weak technical signals, severe fundamental deterioration, and elevated risk metrics paints a cautious outlook for REFR.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish SMA crossover
- Negative earnings and cash flow
- Elevated volatility and drawdown
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for turnaround if capital structure improves
- Technical support near $0.87
- Uncertain market sentiment
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Long‑term industry exposure to smart glass technology
- High valuation multiples remain unjustified
- Continued debt burden limits upside
Key Metrics & Analysis
Financial Health
Revenue Growth-59.50%
Profit Margin-182.44%
P/E Ratio-15.8
ROE-115.64%
ROA-42.36%
Debt/Equity124.92
P/B Ratio33.9
Op. Cash Flow$-1329161
Free Cash Flow$-487032
Industry P/E38.2
Technical Analysis
TrendBearish
RSI48.8
Support$0.87
Resistance$1.02
MA 20$0.95
MA 50$0.97
MA 200$1.39
MACDBullish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.08
Volatility96.68%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.